Changhui Wang Selected Research

CAP1-6D

1/2022	Phosphorylation of CAP1 regulates lung cancer proliferation, migration, and invasion.
8/2019	Adenylyl cyclase‑associated protein 1‑targeted nanoparticles as a novel strategy for the treatment of metastatic non‑small cell lung cancer.
1/2018	Phosphorylation of the Cytoskeletal Protein CAP1 Regulates Non-Small Cell Lung Cancer Survival and Proliferation by GSK3β.
4/2017	Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer.
10/2013	Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Changhui Wang Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 08/2013
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2012
11	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2013
6	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2013
4	Pneumonia (Pneumonitis) 01/2020 - 01/2014
3	Inflammation (Inflammations) 10/2021 - 03/2019
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 05/2016
3	Hypertension (High Blood Pressure) 01/2021 - 01/2015
3	COVID-19 01/2021 - 01/2020
2	Lung Diseases (Lung Disease) 07/2021 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 10/2013
2	Adenocarcinoma 01/2021 - 10/2013
2	Fever (Fevers) 05/2016 - 01/2014
2	Body Weight (Weight, Body) 12/2014 - 03/2014
1	Infections 01/2022
1	Myocarditis (Carditis) 10/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Emphysema 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Heart Failure 01/2021
1	Pulmonary Hypertension 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Vascular Calcification 01/2021
1	Lyme Disease (Disease, Lyme) 06/2020
1	Glioma (Gliomas) 02/2020
1	Atrial Fibrillation 01/2020
1	Human Influenza (Influenza) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2018
1	Disease Progression 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Pleural Tuberculosis 10/2017
1	Chest Pain (Chest Pains) 05/2016
1	Coronary Disease (Coronary Heart Disease) 05/2016
1	Dyspnea (Shortness of Breath) 05/2016
1	Hemoptysis 05/2016
1	Pulmonary Embolism 05/2016
1	Insulin Resistance 07/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2015
1	Asthma (Bronchial Asthma) 04/2015
1	Hepatocellular Carcinoma (Hepatoma) 02/2015

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2013
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2013
5	CAP1-6DIBA 01/2022 - 10/2013
4	Messenger RNA (mRNA)IBA 01/2022 - 10/2013
4	C-Reactive ProteinIBA 01/2021 - 05/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2014
3	HDL CholesterolIBA 01/2020 - 05/2011
3	MicroRNAs (MicroRNA)IBA 01/2018 - 03/2016
2	Biological ProductsIBA 01/2021 - 03/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 10/2017
2	Peptides (Polypeptides)IBA 06/2020 - 02/2020
2	fibrin fragment D (D-dimer)IBA 01/2020 - 05/2016
2	Troponin IIBA 01/2020 - 05/2016
2	Adenylyl Cyclases (Adenylyl Cyclase)IBA 04/2017 - 10/2013
1	NF-kappa B (NF-kB)IBA 10/2021
1	SphingolipidsIBA 07/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 02/2020
1	TropomyosinIBA 02/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Thromboplastin (Tissue Factor)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Nerve Growth Factors (Neurotrophins)IBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	CreatinineIBA 01/2020
1	Vancomycin FDA LinkGeneric 03/2019
1	SmokeIBA 01/2019
1	Hazardous Substances (Hazardous Materials)IBA 01/2019
1	Air Pollutants (Pollutants, Air)IBA 09/2018
1	OzoneIBA 09/2018
1	Particulate MatterIBA 09/2018
1	OxidesIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	ZincIBA 01/2018
1	LigandsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	CarcinogensIBA 01/2018
1	human TNFSF10 proteinIBA 01/2018
1	CopperIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	LipidsIBA 07/2015
1	Calcitriol Receptors (Calcitriol Receptor)IBA 06/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2015
1	IntegrinsIBA 02/2015
1	Streptozocin (Streptozotocin)FDA Link 01/2015
1	SaltsIBA 01/2015

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2014
3	Drug Therapy (Chemotherapy) 08/2020 - 01/2018
2	Radiotherapy 08/2020 - 01/2019
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Length of Stay 01/2021
1	Radiofrequency Ablation 09/2020
1	Adjuvant Chemotherapy 01/2019
1	Quantum Dots (Quantum Dot) 06/2016